Vitiligo

Since the first edition of this book was published, new knowledge has been gained on Vitiligo. This widely revised and updated second edition, written by worldwide experts in the field, fully reflects this progress. The apparently, simple and poorly symptomatic presentation of the disease has been a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Picardo, Mauro (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Taïeb, Alain (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:2nd ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05807nam a2200529 4500
001 978-3-319-62960-5
003 DE-He213
005 20191028132449.0
007 cr nn 008mamaa
008 190723s2019 gw | s |||| 0|eng d
020 |a 9783319629605  |9 978-3-319-62960-5 
024 7 |a 10.1007/978-3-319-62960-5  |2 doi 
040 |d GrThAP 
050 4 |a RL1-803 
072 7 |a MJK  |2 bicssc 
072 7 |a MED017000  |2 bisacsh 
072 7 |a MJK  |2 thema 
082 0 4 |a 616.5  |2 23 
245 1 0 |a Vitiligo  |h [electronic resource] /  |c edited by Mauro Picardo, Alain Taïeb. 
250 |a 2nd ed. 2019. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2019. 
300 |a XVI, 496 p. 174 illus., 160 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preface -- I Defining the Disease -- 1.1 historical aspects -- 1.2 definitions and classification -- 1.3 Epidemiology -- 1.4 Histopathology including electron microscopy -- 1.5 Clinical aspects Including natural history according to subsets -- Short introduction -- 1.5.1 vitiligo including acrofacial, universalis -- 1.5.2 segmental vitiligo Including clinical aspects -- 1.5.3 Mixed vitiligo -- 1.5.4 rare variants including inflammatory -- 1.5.5 subtypes of mucocutaneous pigment cell involvement: mucosal, hair follicle (leukotrichia), nevus cells (halo nevus) -- 1.5.6 extracutaneous melanocytes -- 1.5.7 Environmental triggers: Koebner phenomenon and occupational vitiligo -- 1.5.8 associated disorders and comorbidities includingautoimmune/inflammatory disorders, immunodeficiences, rare monogenic diseases -- 1.5.9 age and vitiligo: childhood, pregnancy, late-onset -- 1.5.10 vitiligo and skin of colour -- 1.6 assessment and scoring including QoL -- 1.7 Editor's synthesis -- II Understanding the Disease -- 2.1 pathophysiology overview -- Unifying concepts V-SV -- 2.2 methods to study vitiligo -- 2.2.1 in vivo confocal microscopy and other noninvasive techniques -- 2.2.2 animal models -- 2.2.3 in vitro -- 2.3 critical assessment of published data on vitiligo Short introduction -- 2.3.1 Genetics -- 2.3.2 epigenetics -- 2.3.3 melanocyte stability -- 2.3.4 oxidative stress and intrinsic melanocyte defects -- 2.3.5 immunity (innate, adaptive). Innate and adaptive separated -- 2.3.6 peptides, growth factors including POMC and family -- 2.3.7 Stem cells -- 2.3.8 other defects and mechanisms -- 2.4 pathophysiology of segmental vitiligo -- 2.5 Editor's synthesis -- III Treating the Disease -- 3.1 management overview -- What has changed in a therapeutic perspective -- 3.2 discussion of available and new therapies -- 3.2.1 medical therapies -- 3.2.2 phototherapies -- 3.2.3 surgical therapies -- 3.2.4 depigmenting therapies -- 3.3combined/sequential/integrated therapies including maintenance therapy -- 3.4 camouflage -- 3.5 photoprotection -- 3.6 age, gender, ethnic skin, specific locations -- 3.7 psychological intervention -- 3.8 patient's perspectives -- 3.9 discussion of empirical, traditional, alternative approaches -- 3.10 evidence-based medicine perspective and guidelines -- 3.11 beyond guidelines -- 3.12 editor's synthesis and perspectives -- Subject Index. . 
520 |a Since the first edition of this book was published, new knowledge has been gained on Vitiligo. This widely revised and updated second edition, written by worldwide experts in the field, fully reflects this progress. The apparently, simple and poorly symptomatic presentation of the disease has been a strong disadvantage to its study, as compared to other common chronic skin disorders such as psoriasis and atopic dermatitis. A good skin-based angle of attack is also lacking because generalized Vitiligo is clearly epitomizing the view of skin diseases as simple targets of a systemic unknown dysregulation (diathesis). This view has mostly restricted Vitiligo to the manifestation of an auto-immune diathesis and skin events, which are easily detected using skin biospies in most other situations, have not been precisely recorded, with the argument that a clinical diagnosis was sufficient for the management of the patient with Vitiligo. This richly illustrated second edition reflects the constant international effort to share the information gathered about this disorder at the clinical, pathophysiological and therapeutic levels. Its aim still being to bridge current knowledge at the clinical and investigative level, to point to the many unsolved issues, and to delineate future priorities for research. 
650 0 |a Dermatology. 
650 0 |a Internal medicine. 
650 0 |a Plastic surgery. 
650 0 |a Human genetics. 
650 0 |a Cell biology. 
650 1 4 |a Dermatology.  |0 http://scigraph.springernature.com/things/product-market-codes/H1900X 
650 2 4 |a Internal Medicine.  |0 http://scigraph.springernature.com/things/product-market-codes/H33002 
650 2 4 |a Plastic Surgery.  |0 http://scigraph.springernature.com/things/product-market-codes/H59087 
650 2 4 |a Human Genetics.  |0 http://scigraph.springernature.com/things/product-market-codes/B12008 
650 2 4 |a Cell Biology.  |0 http://scigraph.springernature.com/things/product-market-codes/L16008 
700 1 |a Picardo, Mauro.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Taïeb, Alain.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319629582 
776 0 8 |i Printed edition:  |z 9783319629599 
856 4 0 |u https://doi.org/10.1007/978-3-319-62960-5  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)